The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability. [...]

This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under threa [...]

The First Widespread Cure for HIV Could Be in Children

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their viral loads to undetectable levels and then come off the medicine. [...]

Five children see HIV viral loads vanish after taking antiretroviral drugs

The first widespread success in curing HIV may come from children, not adults. [...]

Merck's new 2-drug HIV pill wins FDA approval as alternative to 3-drug regimens

Idvynso combines doravirine and islatravir in a once-daily tablet cleared for adults already suppressing HIV on stable therapy [...]

Supercharging Immune Cells May Help Control HIV Long-Term

CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV. [...]

Bill Gates says he will give away almost all of his money over next 20 years

During the 25th anniversary celebration of the Gates Foundation, Bill Gates has announced that he was planning to give away "virtually all" of his wealth within the next 20 years. In all, he [...]

Elon Musk fires back at Bill Gates over claim that DOGE cuts are 'killing' poor children

Elon Musk has hit back at Bill Gates’s claim that his cuts to the U.S. foreign aid budget will kill millions of children.Read more... [...]

FDA approved Gilead's new once-daily HIV pill for patients on complex regimens

Bixlenvo combines two existing Gilead drugs into a single tablet for adults whose virus is suppressed but who can't use current one-pill options [...]